No increased risk of hepatocellular carcinoma after eradication of hepatitis C virus by direct-acting antivirals, compared with interferon-based therapy-Reference-Cited by-同舟云学术

No increased risk of hepatocellular carcinoma after eradication of hepatitis C virus by direct-acting antivirals, compared with interferon-based therapy

Published:2022-08-31 Issue:4 Volume:4 Page:216-224
ISSN:2434-9186
Container-title:Global Health & Medicine
language:en
Short-container-title:GHM

Author:

Korenaga Masaaki¹,Murata Kazumoto²,Izumi Namiki³,Tamaki Nobuharu³,Yokosuka Osamu⁴,Takehara Tetsuo⁵,Sakamoto Naoya⁶,Suda Goki⁶,Nishiguchi Shuhei⁷,Enomoto Hirayuki⁷,Ikeda Fusao⁸,Yanase Mikio⁹,Toyoda Hidenori¹⁰,Genda Takuya¹¹,Umemura Takeji¹²,Yatsuhashi Hiroshi¹³,Yamasaki Kazumi¹³,Ide Tatsuya¹⁴,Toda Nobuo¹⁵,Kanda Tatsuo¹⁶,Nirei Kazushige¹⁶,Ueno Yoshiyuki¹⁷,Haga Hiroaki¹⁷,Nishigaki Yoichi¹⁸,Nakane Kunio¹⁹,Omata Masao²⁰,Mochizuki Hitoshi¹,Aoki Yoshihiko¹,Imamura Masatoshi¹,Kanto Tatsuya¹

Affiliation:

1. The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Ichikawa, Japan.

2. Genome Medical Science Project, National Center for Global Health and Medicine, Ichikawa, Japan.

3. Department of Gastroenterology and Hepatology, Japan Red Cross Musashino Hospital, Tokyo, Japan.

4. Funabashi Central Hospital, Funabashi, Japan.

5. Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Japan.

6. Department of Gastroenterology and Hepatology, Hokkaido University Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

7. Division of Gastroenterology and Hepatology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.

8. Department of Gastroenterology, Okayama University Hospital, Okayama, Japan.

9. Department of Gastroenterology, National Center for Global Health and Medicine, Tokyo, Japan.

10. Department of Gastroenterology, Ogaki Municipal Hospital, Ogaki, Japan.

11. Department of Gastroenterology and Hepatology, Juntendo University Shizuoka Hospital, Izunokuni, Japan.

12. Department of Gastroenterology, Shinshu University School of Medicine, Matsumoto, Japan.

13. Clinical Research Center, National Hospital Organization, Nagasaki Medical Center, Nagasaki, Japan.

14. Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Fukuoka, Japan.

15. Department of Gastroenterology, Mitsui Memorial Hospital, Tokyo, Japan.

16. Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.

17. Department of Gastroenterology, Yamagata University Faculty of Medicine, Yamagata, Japan.

18. Department of Gastroenterology, Gifu Municipal Hospital, Gifu, Japan.

19. Department of Gastroenterology, Akita City Hospital, Akita, Japan.

20. Genome Analysis Center, Yamanashi Prefecture Central Hospital, Yamanashi, Japan.

Publisher

National Center for Global Health and Medicine (JST)

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/ghm/4/4/4_2022.01026/_pdf

Reference31 articles.

1. 1. Thomas DL, Seeff LB. Natural history of hepatitis C. Clin Liver Dis. 2005; 9:383-398.

2. 2. Niederau C, Lange S, Heintges T, Erhardt A, Buschkamp M, Hürter D, Nawrocki M, Kruska L, Hensel F, Petry W, Häussinger D. Prognosis of chronic hepatitis C: results of a large, prospective cohort study. Hepatology. 1998; 28:1687-1695.

3. 3. European Association for the Study of the Liver; European Organization for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012; 56:908-943.

4. 4. Lok AS, Seef LB, Morgan TR, di Bisceglie AM, Sterling RK, Curto TM, Everson GT, Lindsay KL, Lee WM, Bonkovsky HL, Dienstag JL, Ghany MG, Morishima C, Goodman ZD; HALT-C Trial Group. Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease. Gastroenterology. 2009; 136:138-148.

5. 5. Nishiguchi S, Kuroki T, Nakatani S, Morimoto H, Takeda T, Nakajima S, Shiomi S, Seki S, Kobayashi K, Otani S. Randomized trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet. 1995; 346:1051-1055.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liver Transplantation from a Human Leukocyte Antigen-Matched Sibling Donor: Effectiveness of Direct-Acting Antiviral Therapy against Hepatitis C Virus Infection;Reports;2022-12-04